摘要 |
Disclosed are nanoparticles and/or microparticles of hexahydroxy-cyclohexane hexaphosphoric ester salts for the treatment of calcinosis, in particular pseudogout and calcinosis cutis, the hexahydroxy-cyclohexane being selected from among the group consisting of eis-, epi-, allo-, neo-, myo-, muco-, chiro- and scyllo-inositol, in particular myo-inositol; pharmaceutical preparations, in particular for topical application, dietary supplements for food and diet food, especially milk and milk products, containing at least one type of nanoparticles and/or at least one type of microparticles of at least one type of hexahydroxy-cyclohexane hexaphosphoric ester salts; process for synthesizing the pharmaceutical preparations and the diet food. |